347 related articles for article (PubMed ID: 21107351)
1. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.
Yamasaki K; Kanada K; Macleod DT; Borkowski AW; Morizane S; Nakatsuji T; Cogen AL; Gallo RL
J Invest Dermatol; 2011 Mar; 131(3):688-97. PubMed ID: 21107351
[TBL] [Abstract][Full Text] [Related]
2. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.
Coda AB; Hata T; Miller J; Audish D; Kotol P; Two A; Shafiq F; Yamasaki K; Harper JC; Del Rosso JQ; Gallo RL
J Am Acad Dermatol; 2013 Oct; 69(4):570-7. PubMed ID: 23871720
[TBL] [Abstract][Full Text] [Related]
3. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
Front Immunol; 2021; 12():609615. PubMed ID: 34322115
[TBL] [Abstract][Full Text] [Related]
4. Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin.
Lee JB; Bae SH; Moon KR; Na EY; Yun SJ; Lee SC
Exp Dermatol; 2016 Dec; 25(12):956-961. PubMed ID: 27315464
[TBL] [Abstract][Full Text] [Related]
5. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.
Yamasaki K; Di Nardo A; Bardan A; Murakami M; Ohtake T; Coda A; Dorschner RA; Bonnart C; Descargues P; Hovnanian A; Morhenn VB; Gallo RL
Nat Med; 2007 Aug; 13(8):975-80. PubMed ID: 17676051
[TBL] [Abstract][Full Text] [Related]
6. [New insights in the pathogenesis and treatment of rosacea].
Palatsi R; Kelhälä HL; Hägg P
Duodecim; 2012; 128(22):2327-35. PubMed ID: 23342479
[TBL] [Abstract][Full Text] [Related]
7. Colchicine Alleviates Rosacea by Inhibiting Neutrophil Inflammation Activated by the TLR2 Pathway.
Yuan X; Sheng L; Shi G; Jiang L; Lian C
Inflammation; 2024 Jun; 47(3):1002-1014. PubMed ID: 38279067
[TBL] [Abstract][Full Text] [Related]
8.
Roh KB; Ryu DH; Cho E; Weon JB; Park D; Kweon DH; Jung E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256158
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.
Kim JY; Kim YJ; Lim BJ; Sohn HJ; Shin D; Oh SH
Yonsei Med J; 2014 Nov; 55(6):1648-55. PubMed ID: 25323904
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.
Chen M; Xie H; Chen Z; Xu S; Wang B; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Li J; Deng Z
Biomed Pharmacother; 2019 Aug; 116():109011. PubMed ID: 31132668
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress: key promoter of rosacea pathogenesis.
Melnik BC
Exp Dermatol; 2014 Dec; 23(12):868-73. PubMed ID: 25047092
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines.
Shibata M; Katsuyama M; Onodera T; Ehama R; Hosoi J; Tagami H
J Invest Dermatol; 2009 Feb; 129(2):375-82. PubMed ID: 18704103
[TBL] [Abstract][Full Text] [Related]
13. Activation of aryl hydrocarbon receptor ameliorates rosacea-like eruptions in mice and suppresses the TLR signaling pathway in LL-37-induced HaCaT cells.
Sun Y; Chen L; Wang H; Zhu P; Jiang S; Qi R; Wu Y; Gao X
Toxicol Appl Pharmacol; 2022 Sep; 451():116189. PubMed ID: 35926563
[TBL] [Abstract][Full Text] [Related]
14. Innate Immune Dysfunction in Rosacea Promotes Photosensitivity and Vascular Adhesion Molecule Expression.
Kulkarni NN; Takahashi T; Sanford JA; Tong Y; Gombart AF; Hinds B; Cheng JY; Gallo RL
J Invest Dermatol; 2020 Mar; 140(3):645-655.e6. PubMed ID: 31472105
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
[TBL] [Abstract][Full Text] [Related]
16. Epidermal proteases in the pathogenesis of rosacea.
Meyer-Hoffert U; Schröder JM
J Investig Dermatol Symp Proc; 2011 Dec; 15(1):16-23. PubMed ID: 22076323
[TBL] [Abstract][Full Text] [Related]
17. Induction of beta-defensin 3 in keratinocytes stimulated by bacterial lipopeptides through toll-like receptor 2.
Sumikawa Y; Asada H; Hoshino K; Azukizawa H; Katayama I; Akira S; Itami S
Microbes Infect; 2006 May; 8(6):1513-21. PubMed ID: 16697678
[TBL] [Abstract][Full Text] [Related]
18. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea.
Salzer S; Kresse S; Hirai Y; Koglin S; Reinholz M; Ruzicka T; Schauber J
J Dermatol Sci; 2014 Dec; 76(3):173-9. PubMed ID: 25306296
[TBL] [Abstract][Full Text] [Related]
19. Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor.
Two AM; Hata TR; Nakatsuji T; Coda AB; Kotol PF; Wu W; Shafiq F; Huang EY; Gallo RL
J Invest Dermatol; 2014 Apr; 134(4):1143-1145. PubMed ID: 24213369
[No Abstract] [Full Text] [Related]
20. Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes.
Büchau AS; Schauber J; Hultsch T; Stuetz A; Gallo RL
J Invest Dermatol; 2008 Nov; 128(11):2646-2654. PubMed ID: 18496569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
